2024-511119-11-00招募中1 期
A Study of ZW171 in Participants with Advanced or Metastatic Mesothelin Expressing Cancers
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 9
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Medical Officer
Scientific
Zymeworks Inc.
研究点 (3)
Loading locations...
相似试验
未知
2 期
A Phase IIa Study of Z-207 in Patients with Seasonal Allegic Rhinitis - Investigation of the Efficacy and Safety of Z-207 after Single InjectionSeasonal Allergic RhinitisJPRN-jRCT2080221241Zeria Pharmaceutical Co., Ltd.48
进行中（未招募）
1 期
A Phase 2 Study of XL147 in Subjects with Advanced or Recurrent Endometrial CarcinomaThe purpose of this study is to assess the efficacy and safety of XL147 in subjects with advanced or recurrent EC.MedDRA version: 14.0Level: LLTClassification code 10014747Term: Endometrial carcinoma recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-016707-30-BESanofi-aventis US Inc.80
进行中（未招募）
1 期
A Phase 2 Study of XL147 in Subjects with Advanced or Recurrent Endometrial CarcinomaEUCTR2009-016707-30-FRExelixis, Inc.80
终止
1 期
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing CancersMesothelin-expressing Advanced CancersNCT06523803Zymeworks BC Inc.32
进行中（未招募）
1 期
A Phase 1 and 2 Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of AZD8233 Following a Multiple Subcutaneous Dose Administration in Japanese Participants With DyslipidemiaDyslipidemiaJPRN-jRCT2051210041Hibi Kazushige91